The agreement gives Fresenius exclusive option rights for up to 37 potential first-to-market biosimilar candidates ...

Commercial engagement in biopharma was once relatively straightforward, centred on a sales rep speaking directly with a ...

AbbVie has announced the expansion of its UK R&D facility, AbbVie Oxford. The new 12,000-square-foot site will expand ...

We also need to understand the information ecosystem shaping their knowledge and decisions. Scientific engagement has always ...

Volatility is reshaping the conditions for successful product launches. Market dynamics can shift quickly, assumptions can ...

AI is creating a world of opportunities for pharma companies to deliver more personalized HCP and patient engagement. But ...

Karyopharm Therapeutics, a commercial-stage pharmaceutical company pioneering novel cancer therapies, has announced that it ...

The life sciences industry is changing fast. Advances in AI, increasingly complex science, shifting market dynamics and ...

Social media is healthcare’s new superhero, full of high-flying promise and an armoury of positive patient and HCP ...

The companies that prevail will not be those with the best assets, but those that help build an integrated ecosystem around ...

Only 19% of clinicians trust pharma-branded touchpoints, while 86% trust peer-to-peer content. It’s a new reality for medical ...

Close your eyes and picture somewhere that scares you. A small tunnel? The edge of a cliff? Your ex’s dinner table? For me, it’s the alternate version of my ...